Nishina K, Mikawa K, Maekawa N, Takao Y, Obara H
Department of Anaesthesiology, Kobe University School of Medicine, Japan.
Anesth Analg. 1994 Oct;79(4):766-8. doi: 10.1213/00000539-199410000-00025.
Clonidine is a useful drug to give preoperatively because it produces anxiolysis, sedation, and hemodynamic stability, and reduces intravenous and volatile anesthetic requirements. Several premedicants, including midazolam and diazepam, have been shown to reduce the induction dose of intravenous anesthetics, such as thiopental, ketamine, or propofol. A randomized, double-blind controlled study was conducted to evaluate the effect of premedication with oral clonidine on thiamylal requirement for the induction of anesthesia and on associated hemodynamic changes in children. Sixty children (ASA grades I-II, 7-12 yr old) were assigned randomly to receive one of three treatments (n = 20, for each group): placebo (control), clonidine 2 micrograms/kg, or clonidine 4 micrograms/kg 105 min before the induction of anesthesia. Thiamylal was injected at a dose of 1 mg/kg every 15 s until loss of the eyelash reflex and the dose was recorded. Blood pressure (BP), heart rate (HR), and arterial oxygen saturation were recorded every minute from the beginning of injection of thiamylal for 5 min. Significant decreases in thiamylal dose were observed in patients receiving clonidine. The induction dose of thiamylal (mean +/- SD) was 5.4 +/- 0.9, 4.5 +/- 1.1, and 3.4 +/- 0.9 mg/kg for patients receiving placebo, clonidine 2 micrograms/kg, and clonidine 4 micrograms/kg, respectively (P < 0.05). Systolic BP decreased by 6.8%, 5.6%, and 6.6% and HR increased by 5.7%, 4.8%, and 4.1% after administration of thiamylal in the control (placebo) group and the clonidine 2 micrograms/kg and clonidine 4 micrograms/kg groups, respectively (P > 0.05). Premedication with oral clonidine reduced the dose of intravenous thiamylal required for the induction of anesthesia in children.
可乐定是一种术前使用的有效药物,因为它能产生抗焦虑、镇静作用,维持血流动力学稳定,并降低静脉和挥发性麻醉药的需求量。包括咪达唑仑和地西泮在内的几种术前用药已被证明可降低硫喷妥钠、氯胺酮或丙泊酚等静脉麻醉药的诱导剂量。本研究进行了一项随机双盲对照试验,以评估口服可乐定术前用药对硫喷妥钠诱导麻醉的需求量及对小儿相关血流动力学变化的影响。60例儿童(ASA分级I-II级,7-12岁)随机分为三组(每组n = 20),分别接受以下三种治疗:安慰剂(对照组)、2μg/kg可乐定或4μg/kg可乐定,给药时间为麻醉诱导前105分钟。每隔15秒静脉注射硫喷妥钠,剂量为1mg/kg,直至睫毛反射消失,并记录所需剂量。从硫喷妥钠注射开始记录5分钟内每分钟的血压(BP)、心率(HR)和动脉血氧饱和度。接受可乐定治疗患儿的硫喷妥钠剂量显著降低。接受安慰剂、2μg/kg可乐定和4μg/kg可乐定治疗的患儿,硫喷妥钠诱导剂量(均值±标准差)分别为5.4±0.9、4.5±1.1和3.4±0.9mg/kg(P<0.05)。对照组(安慰剂组)、2μg/kg可乐定组和4μg/kg可乐定组在注射硫喷妥钠后,收缩压分别下降6.8%、5.6%和6.6%,心率分别增加5.7%、4.8%和4.1%(P>0.05)。口服可乐定术前用药可降低小儿麻醉诱导所需的静脉硫喷妥钠剂量。